RedChip Companies will air interviews with Nexalin Technology, Inc. (Nasdaq:NXL) and Calidi Biotherapeutics, Inc. (NYSE American:CLDI) on the RedChip Small Stocks, Big Moneyâ„¢ show, a sponsored program ...
Nexalin believes its neurostimulation medical devices can penetrate structures deep in the mid-brain that are associated ... including high-grade gliomas and solid tumors. Calidi's clinical ...
ORLANDO, FL / ACCESS Newswire / March 14, 2025 / RedChip Companies will air interviews with Nexalin Technology, Inc. (Nasdaq:NXL) and Calidi Biotherapeutics, Inc. (NYSE American:CLDI) on the RedChip S ...
Following additional medical examinations, the diagnosis was determined to be bleeding in the midbrain due to a benign lesion with a cluster of abnormal blood capillaries (cavernous hemangioma).
A unique protein designed by Cedars-Sinai Cancer investigators can cross the protective blood–brain barrier safely and deliver therapy directly into cancerous tumor cells, a preclinical study shows.